PETX
D.E. Shaw & Co’s Aratana Therapeutics, Inc. PETX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-53,420
| Closed | -$327K | – | 2732 |
|
|
2017
Q3 | $327K | Buy |
53,420
+15,023
| +39% | +$92K | ﹤0.01% | 2204 |
|
|
2017
Q2 | $278K | Buy |
38,397
+26,277
| +217% | +$190K | ﹤0.01% | 2166 |
|
|
2017
Q1 | $64K | Sell |
12,120
-117,459
| -91% | -$620K | ﹤0.01% | 2365 |
|
|
2016
Q4 | $930K | Sell |
129,579
-145,403
| -53% | -$1.04M | ﹤0.01% | 1774 |
|
|
2016
Q3 | $2.57M | Buy |
+274,982
| New | +$2.57M | ﹤0.01% | 1244 |
|
|
2016
Q2 | – | Sell |
-158,253
| Closed | -$874K | – | 2768 |
|
|
2016
Q1 | $874K | Buy |
158,253
+146,206
| +1,214% | +$807K | ﹤0.01% | 1807 |
|
|
2015
Q4 | $67K | Buy |
+12,047
| New | +$67K | ﹤0.01% | 2562 |
|
|
2015
Q3 | – | Sell |
-51,492
| Closed | -$779K | – | 2804 |
|
|
2015
Q2 | $779K | Buy |
+51,492
| New | +$779K | ﹤0.01% | 1970 |
|
|
2015
Q1 | – | Sell |
-677,778
| Closed | -$12.1M | – | 2748 |
|
|
2014
Q4 | $12.1M | Buy |
677,778
+10,626
| +2% | +$189K | 0.02% | 592 |
|
|
2014
Q3 | $6.7M | Buy |
667,152
+255,052
| +62% | +$2.56M | 0.01% | 775 |
|
|
2014
Q2 | $6.43M | Buy |
412,100
+60,032
| +17% | +$937K | 0.01% | 803 |
|
|
2014
Q1 | $6.53M | Buy |
352,068
+236,895
| +206% | +$4.4M | 0.01% | 772 |
|
|
2013
Q4 | $2.2M | Sell |
115,173
-106,514
| -48% | -$2.03M | ﹤0.01% | 1248 |
|
|
2013
Q3 | $3.62M | Sell |
221,687
-16,065
| -7% | -$262K | 0.01% | 982 |
|
|
2013
Q2 | $1.8M | Buy |
+237,752
| New | +$1.8M | ﹤0.01% | 1260 |
|